HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

(3-aminopropyl)(n-butyl)phosphinic acid

interacts preferably with GABA-B RECEPTORS (IC50=38 μM) and GABA-C receptors (IC50=62 μM) over GABA-A RECEPTORS (IC50=508 μM)
Also Known As:
3-aminopropyl-n-butyl phosphinic acid; CGP 36742; CGP-36742; CGP36742; SGS-742; SGS742
Networked: 14 relevant articles (1 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Goodwin, Amy K: 2 articles (07/2005 - 05/2005)
2. Weerts, Elise M: 2 articles (07/2005 - 05/2005)
3. Froestl, Wolfgang: 2 articles (07/2005 - 05/2005)
4. Brown, P Rand: 1 article (05/2005)
5. Griffiths, Roland R: 1 article (05/2005)
6. Gibson, K Michael: 1 article (05/2005)
7. Jakobs, Cornelis: 1 article (05/2005)
8. Lichtman, A H: 1 article (03/2005)
9. Niyuhire, F: 1 article (03/2005)
10. Anum, E: 1 article (03/2005)

Related Diseases

1. Absence Epilepsy (Absence Seizure)
2. Memory Disorders (Memory Loss)
3. Ataxia (Dyssynergia)
4. Seizures (Seizure)
5. Alzheimer Disease (Alzheimer's Disease)

Related Drugs and Biologics

1. gamma-Aminobutyric Acid (GABA)
2. Baclofen
3. Scopolamine (Hyoscine)
4. Fibroblast Growth Factor 7
5. Brain Natriuretic Peptide (Natrecor)
6. Nelfinavir (Viracept)
7. Ritonavir (Norvir)
8. Filgrastim (Neupogen)
9. GTP-Binding Proteins (G-Protein)
10. Ritanserin

Related Therapies and Procedures

1. Oral Administration
2. Stents
3. Intraperitoneal Injections
4. Electrodes (Electrode)
5. Analgesia